MSU
BIO icon

Mizuho Securities USA’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mizuho Securities USA’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,572
Closed -$429K – 622
2024
Q2 		$429K Buy
+1,572
New +$457K 0.01% 588

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mizuho Securities USA's BIO Position: Q3 2024 in Review

Mizuho Securities USA sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 1,572 shares — an estimated $429K sold.

Mizuho Securities USA first reported a position in BIO in Q2 2024 and held it in 1 quarter. The position peaked at $429K in Q2 2024. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Mizuho Securities USA reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Mizuho Securities USA sold 1,572 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $429K.
  • Mizuho Securities USA first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and held it in 1 quarter.
  • Mizuho Securities USA's Bio-Rad Laboratories Class A position peaked at $429K in Q2 2024.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Mizuho Securities USA's 13F filing for Q3 2024, filed 6 Nov 2024.